Average Co-Inventor Count = 5.49
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Consejo Nacional De Investigaciones Cientificas Y Tecnicas (conicet) (6 from 74 patents)
2. Fundacion Sales (6 from 8 patents)
3. Dana-farber-cancer Institute Inc. (5 from 1,206 patents)
4. The Brigham and Women's Hospital, Inc. (3 from 1,370 patents)
5. Inis Biotech LLC (2 from 20 patents)
6. Conicet (1 from 2 patents)
7. Funadción Sales (1 from 1 patent)
8. Consejo Nactional De Investigaciones Cientificias Y Tecnicas (1 from 1 patent)
9. Consejo Nacional De Investigaciones Cientificas Y Tecnicas (1 patent)
8 patents:
1. 11723972 - Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
2. 11020478 - Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment
3. 10456465 - Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
4. 10456447 - Therapeutic modulation of skin immune system with Gal-7
5. 10294295 - Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment
6. 9939428 - Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1
7. 9206427 - Compositions, kits, and methods for the modulation of immune responses using galectin-1
8. 8968740 - Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1